These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33029084)

  • 1. Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.
    Sun Y; Chen X; Zhou Y; Qiu S; Wu Y; Xie M; Zhu G; Liang S; Li H; Zhou D; Ju Z; Wang F; Han F; Wang Z; Wang R
    Int J Med Sci; 2020; 17(16):2416-2426. PubMed ID: 33029084
    [No Abstract]   [Full Text] [Related]  

  • 2. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
    Peng X; Li W; Tan G
    Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.
    Sun XJ; Zhang P; Li HH; Jiang ZW; Jiang CC; Liu H
    Asian Pac J Cancer Prev; 2014; 15(9):4019-23. PubMed ID: 24935589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells.
    Shi L; Mei Y; Duan X; Wang B
    Comput Math Methods Med; 2022; 2022():2056247. PubMed ID: 35422875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
    Zhang H; Lu J; Jiang C; Lu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
    Song Y; Zhou X; Bai W; Ma X
    Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
    Yin P; Song G; Jiang Z
    Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
    Wang X; Wang K; Xiao J; Song Y; Li H
    Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
    Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
    Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
    Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
    Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.
    Liu J; Zhu M; Feng Y; Tang Q; Xu M
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts.
    Chen Z; Zeng Z; Zhu S; Zeng Y; Lin Q; Luo L; Hong X
    Sci Rep; 2021 Jan; 11(1):1040. PubMed ID: 33441838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis.
    Zhang HX; Deng C; Liu OS; Liu XL; Wu F; Wang JJ; Feng YQ; Hu CH; Tang ZG
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2789-97. PubMed ID: 25339471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.
    Zhou C; Shen G; Yang F; Duan J; Wu Z; Yang M; Liu Y; Du X; Zhang X; Xiao S
    J Cell Mol Med; 2020 Jun; 24(11):6438-6447. PubMed ID: 32307891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.
    Xie SM; Fang WY; Liu Z; Wang SX; Li X; Liu TF; Xie WB; Yao KT
    J Transl Med; 2008 Oct; 6():55. PubMed ID: 18834541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.